SIRTeX SIR-Spheres PMA Supplement Submission Expected By Year-End
This article was originally published in The Gray Sheet
Executive Summary
SIRTeX Medical is looking to follow its March 5 SIR-Spheres PMA approval for localized treatment of unresectable metastatic liver tumors with a PMA supplement submission by the end of the year for a systemic indication